GlassScriptPhysician profile
Charles S Coffey
NPI 1932297330
$19,876.21
in general payments reported to CMS, 2019-2025
11 companies · $52.61 in 2025
The $52.61 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $14.13 · 2021: $1,332 · 2022: $65.60 · 2023: $3,300 · 2024: $329 · 2025: $52.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $536 · Food and Beverage: $535 · Long Term Medical Supply Or Device Loan: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $536.35 |
| Food and Beverage | $534.58 |
| Long Term Medical Supply Or Device Loan | $110.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $14,659.06 | 2019 | |
| Intuitive Surgical, INC. | $3,052.35 | 2023 | Da Vinci Sp, Da Vinci Surgical System |
| Impactortho, INC. | $1,200.00 | 2021 | |
| Integra Lifesciences Corporation | $242.20 | 2020-2024 | Acell, Integra, Primatrix |
| Tactile Systems Technology INC | $215.47 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Merz North America, INC. | $165.98 | 2023 | Xeomin |
| Kls-Martin L.P. | $157.11 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $60.22 | 2022-2023 | |
| Karl Storz Endoscopy-America | $54.18 | 2019 | |
| Cook Medical LLC | $49.87 | 2019 | |
| Stryker Corporation | $19.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Coffey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.